- 询价
- Nebulabio
- 中国
- NBL-293994
- 2026年01月15日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 规格：
100ug; 500ug; 1mg; Bulk
| 产品信息
品名：NebuSelect™ Recombinant Human CD38 Protein, 43-300aa, Fc-tag
中文名称：重组人CD38蛋白
别名：ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, EC:3.2.2.-, EC:3.2.2.6, 2'-phospho-ADP-ribosyl cyclase, 2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase, EC:2.4.99.20, 2'-phospho-cyclic-ADP-ribose transferase, ADP-ribosyl cyclase 1, ADPRC 1, Cyclic ADP-ribose hydrolase 1, cADPR hydrolase 1, T10, CD38, CD38
货号：NBL-293994
品牌：Nebulabio
规格：100UG；1MG；Bulk
| 产品描述
NebuSelect™ Recombinant Human CD38 Protein, Fc-tag (Cat# NBL-293994) is expressed in HEK293 Cells with Fc Tag. This recombinant protein is of high purity, verified to be greater than 90% by SDS-PAGE. Endotoxin levels are less than 1 EU/µg, as determined by the LAL (Limulus Amebocyte Lysate) assay.
| 产品属性
Species:Human
Expression System:HEK293 Cells
Molecular Weight:58 kDa
Target Name:CD38
Purity:>90% by SDS-PAGE.
Formulation:See COA
Endotoxin:＜1 EU/ug(LAL Method)
Storage:4°C for short term. -20°C for long term.
For Research Use Only!
To get more information, please contact us freely.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Assessing Fc Glycan Heterogeneity of Therapeutic Recombinant Monoclonal Antibodies Using NP-HPLC
Recombinant monoclonal antibodies (rMAbs) are becoming major human therapeutics to treat life-threatening diseases such as cancer. These rMAbs are produced using either in vitro cell culture processes or transgenic technology in animals
human E-cadherin-IgG Fc domain fusion protein (E-cad-Fc) has recently been shown to be extremely efficient in facilitating the culture of human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells under completely defined conditions
三句话读懂一篇 CNS：晚睡晚起导致抑郁；吃药代替运动健身；高脂肪饮食引发结直肠癌...
结构 研究表明 LRRK2 蛋白酶突变是导致帕金森病的关键原因之一。 2021 年 6 月 8 日，圣裘德儿童研究医院孙吉教授团队在 Cell 上发表研究论文 Structural analysis of the full-length human LRRK2，该研究首次解析了人类 LRRK2 全长蛋白的高分辨率结构，为人类战胜帕金森病提供了理论参考。图 6：来源 Cell 7. Lacent: 父母学历越高，所生小孩死亡率越低 2021 年 6 月 10 日，挪威科技大学 Terje
技术资料暂无技术资料 索取技术资料
